In a small cell therapy trial, 10 out of 12 participants with type 1 diabetes no longer required supplemental insulin one year after treatment. This represents a promising advancement in diabetes management.
Trial Results
The therapy involved implanting lab-grown cells that produce insulin, showing long-term efficacy in most patients.
Future Prospects
Larger trials are planned to confirm safety and effectiveness.